Brief: Glenmark Pharma, Cosmo Announce Market Authorization Of Winlevi In Europe
18/11/2025 09:34
Nov 18 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS: GLENMARK PHARMA - COSMO AND GLENMARK ANNOUNCE MARKET AUTHORIZATION OF WINLEVI IN EUROPE GLENMARK PHARMA - GLENMARK WILL INITIATE COMMERCIALIZING WINLEVI ACROSS 15 COUNTRIES IN EU Source text: ID:nBSEbBKhHK Further company coverage: GLEN.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter